Alexandra Balcom, Chief Financial Officer at Nuvalent, Inc. (NUVL), sold 25,246 shares at $85.10 ($2.1M) on 2025-07-16, disclosed to the SEC on 2025-07-17.
Scheduled sale ($2.1M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.67 | 2,484 | $205K | 9.6% |
| 2 | $82.67 | 2,484 | $205K | 9.6% |
| 3 | $83.87 | 1,888 | $158K | 7.4% |
| 4 | $83.87 | 1,888 | $158K | 7.4% |
| 5 | $84.91 | 874 | $74K | 3.5% |
| 6 | $84.91 | 874 |
| $74K |
| 3.5% |
| 7 | $85.48 | 54 | $5K | 0.2% |
| 8 | $85.10 | 14,700 | $1.3M | 58.7% |
| Total | $84.43 avg | 25,246 | $2.1M | 100% |
| Filing → |
| NUVL | SELL | 2026-05-05 | $1.1M | — | Filing → |
| NUVL | SELL | 2026-04-03 | $1.2M | — | Filing → |
| NUVL | SELL | 2026-03-26 | $2.5M | — | Filing → |